Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3202818rdf:typepubmed:Citationlld:pubmed
pubmed-article:3202818lifeskim:mentionsumls-concept:C0030193lld:lifeskim
pubmed-article:3202818lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:3202818lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:3202818lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:3202818lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:3202818pubmed:issue3lld:pubmed
pubmed-article:3202818pubmed:dateCreated1989-1-25lld:pubmed
pubmed-article:3202818pubmed:abstractTextFighting pairs of isolated DBA/2 mice showed a significant increase in tail-flick response latencies independent of whether opponents were losing or winning the combat. The effect lasted less than 10 min in both animals. Elevated pain thresholds were also found in isolates that attacked a nonaggressive conspecific, and were prevented by naltrexone (0.2 mg/kg), while a larger dose (1.0 mg/kg) inhibited the attack behavior. A small increase in pain threshold was observed after exposure of isolates to the test box alone, while isolation per se had no effect on baseline tail-flick latencies. The data demonstrate that endogenous pain suppressing systems are activated during attack and suggest that this opioid-mediated antinociception is a correlate of the isolation syndrome, reflecting enhanced arousal of the attacking animal.lld:pubmed
pubmed-article:3202818pubmed:languageenglld:pubmed
pubmed-article:3202818pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3202818pubmed:citationSubsetIMlld:pubmed
pubmed-article:3202818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3202818pubmed:statusMEDLINElld:pubmed
pubmed-article:3202818pubmed:monthNovlld:pubmed
pubmed-article:3202818pubmed:issn0163-1047lld:pubmed
pubmed-article:3202818pubmed:authorpubmed-author:SiegfriedBBlld:pubmed
pubmed-article:3202818pubmed:authorpubmed-author:FrischknechtH...lld:pubmed
pubmed-article:3202818pubmed:issnTypePrintlld:pubmed
pubmed-article:3202818pubmed:volume50lld:pubmed
pubmed-article:3202818pubmed:ownerNLMlld:pubmed
pubmed-article:3202818pubmed:authorsCompleteYlld:pubmed
pubmed-article:3202818pubmed:pagination354-60lld:pubmed
pubmed-article:3202818pubmed:dateRevised2006-5-16lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:meshHeadingpubmed-meshheading:3202818-...lld:pubmed
pubmed-article:3202818pubmed:year1988lld:pubmed
pubmed-article:3202818pubmed:articleTitleNaltrexone-reversible pain suppression in the isolated attacking mouse.lld:pubmed
pubmed-article:3202818pubmed:affiliationInstitute of Pharmacology, University of Zurich, Switzerland.lld:pubmed
pubmed-article:3202818pubmed:publicationTypeJournal Articlelld:pubmed